Recent advances and developments in COVID‐19 in the context of allergic diseases

Background Since the first reports of coronavirus disease 2019 (COVID‐19) in Wuhan, China, in December 2019, there have been 198 million confirmed cases worldwide as of August 2021. The scientific community has joined efforts to gain knowledge of the newly emerged virus named severe acute respirator...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	Clinical and translational allergy Jg. 11; H. 7; S. e12065 - n/a
Hauptverfasser:	Ding, Mei, Dong, Xiang, Sun, Yuan‐li, Sokolowska, Milena, Akdis, Mübeccel, Veen, Willem, Azkur, Ahmet Kursat, Azkur, Dilek, Akdis, Cezmi A., Gao, Ya‐dong
Format:	Journal Article
Sprache:	Englisch
Veröffentlicht:	England John Wiley & Sons, Inc 01.09.2021 John Wiley and Sons Inc Wiley
Schlagworte:	Allergies allergy Asthma Biomarkers Clinical outcomes Coronaviruses COVID-19 Cytokines Disease Gene expression Genotype & phenotype Hay fever Immunotherapy Impfung Infections Inflammation mechanism Mechanismen Medical supplies Mortality Pandemics Proteins Review Rhinitis Schlüsselwörter: Allergie Severe acute respiratory syndrome coronavirus 2 Therapie treatment vaccination Viral infections Viruses United Kingdom > UK COVID-19 Mechanismen treatment Therapie Impfung Schlüsselwörter: Allergie allergy mechanism vaccination
ISSN:	2045-7022, 2045-7022
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Schreiben Sie den ersten Kommentar!